Quest Diagnostics
DGX
#1037
Rank
โ‚น2.049 T
Marketcap
โ‚น18,424
Share price
0.33%
Change (1 day)
23.37%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2025 (TTM): โ‚น747.04

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is โ‚น796.44. In 2024 the company made an earnings per share (EPS) of โ‚น717.16 an increase over its 2023 EPS that were of โ‚น699.65.

EPS history for Quest Diagnostics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น747.044.17%
2024โ‚น717.162.5%
2023โ‚น699.65-5.83%
2022โ‚น742.97-49.21%
2021โ‚น1,46349.72%
2020โ‚น977.1166.67%
2019โ‚น586.2618%
2018โ‚น496.85-4.26%
2017โ‚น518.9723.19%
2016โ‚น421.26-7.11%
2015โ‚น453.5328.46%
2014โ‚น353.05-31.61%
2013โ‚น516.2160.46%
2012โ‚น321.71

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
LabCorp
LH
โ‚น944.85 18.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-โ‚น65.61-108.24%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น81.12-110.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น181.32-77.23%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-โ‚น19.36-102.43%๐Ÿ‡บ๐Ÿ‡ธ USA